The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C., Rawls, John F., David, Lawrence A., Hunault, Gilles, Oberti, Frédéric, Calès, Paul, Diehl, Anna Mae·2016·Hepatology
DOI 10.1002/hep.28356

Cited by (999)

Items 601–700 of 999

  1. Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
    Sonja Lang, Anna Martin, Xinlian Zhang, Fedja Farowski, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild, Marcin Jan Krawczyk, Angela Nowag, Anne Kretzschmar, Claus Jürgen Scholz et al. · 2021 · Liver International
  2. The Role of the Microbiome in Liver Cancer
    Mar Moreno‐Gonzalez, Naiara Beraza · 2021 · Cancers
  3. Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice
    Fei Xiong, Zhongdaixi Zheng, Lingyu Xiao, Chuhong Su, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Huiyu Luo, Longying Zha · 2021 · Molecular Nutrition & Food Research
  4. Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
    Kattayoun Kordy, Fan Li, David Lee, Jason Michael Kinchen, Michael Jew, Maria Eduarda La Rocque, Sara Zabih, Monica Saavedra, Cora L. Woodward, Nicole J. Cunningham et al. · 2021 · Frontiers in Microbiology
  5. In Vitro Hepatoprotective and Human Gut Microbiota Modulation of Polysaccharide-Peptides in Pleurotus citrinopileatus
    Yihua Huang, Yi Gao, Xionge Pi, Shuang Zan Zhao, Wei Liu · 2022 · Frontiers in Cellular and Infection Microbiology
  6. DHA-enriched phosphatidylcholine from Clupea harengus roes regulates the gut–liver axis to ameliorate high-fat diet-induced non-alcoholic fatty liver disease
    Li Qian, Shanshan Tian, Su Jiang, Yunping Tang, Tao Han · 2022 · Food & Function
  7. Gut microbiome and nonalcoholic fatty liver disease
    Mengyuan Wu, Jian‐Gao Fan · 2023 · Hepatobiliary & pancreatic diseases international
  8. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma
    Yishu Tang, Hang Zhou, Yu Xiang, Fang Cui · 2020 · European Journal of Gastroenterology & Hepatology
  9. Liver Steatosis is a Driving Factor of Inflammation
    Raja Gopal Reddy Mooli, Sadeesh Kumar Ramakrishnan · 2022 · Cellular and Molecular Gastroenterology and Hepatology
  10. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
    Javier Martínez‐Sanz, Alba Talavera-Rodríguez, Jorge Díaz-Álvarez, Marta Rosas Cancio-Suárez, Juan Miguel Rodríguez, Claudio Alba, Marisa Montes, Rosa Martín‐Mateos, Diego Burgos‐Santamaría, Santiago Moreno et al. · 2023 · Frontiers in Immunology
  11. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
    Simona Cernea · 2024 · Life
  12. Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment
    Lingling Wang, Huiguo Liu, Ling Zhou, Pengdou Zheng, Hai Li, Huojun Zhang, Wei Liu · 2024 · Nature and Science of Sleep
  13. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
    Nikolaos Koukias, Elena Buzzetti, Emmanuel A. Tsochatzis · 2017 · Minerva Endocrinology
  14. Molokhia leaf extract prevents gut inflammation and obesity
    Hye‐Bin Lee, Mi‐Jin Oh, Moon Ho Do, Young‐Soo Kim, Ho‐Young Park · 2020 · Journal of Ethnopharmacology
  15. Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease
    Eric K. Kwong, Puneet Puri · 2020 · Translational Gastroenterology and Hepatology
  16. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic‑associated fatty liver disease in mice
    Kai Kang, Yue Sun, Dan Pan, Li-Xuan Sang, Mingjun Sun, Yiling Li, Bing Chang · 2021 · Experimental and Therapeutic Medicine
  17. Intestinal aberrant sphingolipid metabolism shaped‐gut microbiome and bile acids metabolome in the development of hepatic steatosis
    Rong‐Rong Miao, Sheng Zhan, Shu‐Xiang Cui, Xian‐Jun Qu · 2022 · The FASEB Journal
  18. Association between serum soluble CD 14 and IL ‐8 levels and clinical outcome in primary biliary cholangitis
    Takeji Umemura, Tomohiro Sekiguchi, Satoru Joshita, Tomoo Yamazaki, Naoyuki Fujimori, Soichiro Shibata, Yuki Ichikawa, Michiharu Komatsu, Akihiro Matsumoto, Zakera Shums et al. · 2016 · Liver International
  19. Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in�adults with non‑alcoholic fatty liver disease
    Katherine J. P. Schwenger, Lina Chen, Adeline Chelliah, Hannah Da Silva, Anastasia A. Teterina, Elena M. Comelli, Amel Taïbi, Bianca Maria Arendt, Sandra Elisabeth Fischer, Johane P. Allard · 2018 · International Journal of Molecular Medicine
  20. The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
    Huanzhuo Mai, Xing Hua Yang, Yulan Xie, Jie Zhou, Qing Wang, Yiru Wei, Yuecong Yang, Dongjia Lu, Li Ye, Ping Cui et al. · 2024 · Frontiers in Microbiology
  21. Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial
    Qiaohong Liu, Xiaojing Li, Yuqing Pan, Qian Liu, Ying Li, Cong He, Ningning Zheng, Yan Wang, Huichao Wang, Yan Wang et al. · 2024 · Phytomedicine
  22. The gut-liver axis in fatty liver disease: role played by natural products
    Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Xintian Lan · 2024 · Frontiers in Pharmacology
  23. Peptidoglycan isolated from the fruit of Lycium barbarum alleviates liver fibrosis in mice by regulating the TGF-β/Smad7 signaling and gut microbiota
    Yingmin Nie, Wanqi Zhou, Ting Niu, Mengfei Mao, Yuxue Zhan, Yun Li, Kaiping Wang, Meixia Li, Kan Ding · 2025 · Acta Pharmacologica Sinica
  24. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
    Farah Abdelhameed, Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Nwe Ni Than, Eva N. Kassi, Ioannis Kyrou, Harpal Singh Randeva · 2025 · Livers
  25. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets
    Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada · 2020 · Nutrients
  26. Functional hydrocolloids, gut microbiota and health: picking food additives for personalized nutrition
    Huizi Tan, Shaoping Nie · 2020 · FEMS Microbiology Reviews
  27. Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
    Hui-Ju Tsai, Yi‐Chun Tsai, Wei‐Wen Hung, Wei‐Chun Hung, Chen-Chia Chang, Chia‐Yen Dai · 2021 · Journal of Personalized Medicine
  28. Microbiota and viral hepatitis: State of the art of a complex matter
    Ivana Milošević, Edda Russo, Ankica Vujović, Aleksandra M. Barac, Olja Stevanović, Stefano Gitto, Amedeo Amedei · 2021 · World Journal of Gastroenterology
  29. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study
    Kaushal, Kanav, Agarwal, Samagra, Sharma, Sanchit, Goswami, Pooja, Singh, Namrata, Sachdev, Vikas, Poudel, Shekhar, Das, Prasenjit, Yadav, Rajni, Kumar, Dinesh et al. · 2022 · Journal of Clinical and Experimental Hepatology
  30. The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
    Tsung‐Po Chen, Hui‐Chieh Yu, Wen‐Yuan Lin, Yu‐Chao Chang · 2023 · Journal of Dental Sciences
  31. Limosilactobacillus Fermentum, Lactococcus Lactis and Erysipelatoclostridium ramosum are Enriched and Methanobrevibacter smithii is Depleted in Patients with Non-Alcoholic Steatohepatitis
    Babacar Mbaye, Reham Magdy Wasfy, Maryam Tidjani Alou, Patrick Borentain, Claudia Andrieu, Aurélia Caputo, Didier Raoult, René Gerolami, Matthieu Million · 2023 · Microbial Pathogenesis
  32. Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study
    Fusheng Xu, Ruimin Chen, Chengcheng Zhang, Hao Wang, Zhijie Ding, Leilei Yu, Fengwei Tian, Wei Chen, Yongping Zhou, Qixiao Zhai · 2023 · Nutrients
  33. Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH
    Woestemeier, Anna, Scognamiglio, Pasquale, Zhao, Yu, Wagner, Jonas, Muscate, Franziska, Casar, Christian, Siracusa, Francesco, Cortesi, Filippo, Agalioti, Theodora, Müller, Simone et al. · 2023 · JCI Insight
  34. Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis
    Xiaopei Liu, Dan Liu, Conge Tan, Wenzhe Feng · 2023 · BMC Medical Informatics and Decision Making
  35. Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
    Congzhi Yan, Jingxia Bao, Jinji Jin · 2024 · Journal of Translational Medicine
  36. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis
    Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Razvan Catalin Popescu, Mihaela Butcaru Pundiche, Eugen Dumitru, Sorin Rugină, Cristina Tocia · 2024 · International Journal of Molecular Sciences
  37. Bioactive metabolites: A clue to the link between MASLD and CKD?
    Wen‐Ying Chen, Jia-Hui Zhang, Lili Chen, Christopher D. Byrne, Giovanni Targher, Liangping Luo, Yan Ni, Ming‐Hua Zheng, Dan‐Qin Sun · 2024 · Clinical and Molecular Hepatology
  38. Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation
    James B. Maurice, Lucy J Garvey, Emmanuel A. Tsochatzis, Matthew Wiltshire, Graham Cooke, Naomi Guppy, Julie A. K. McDonald, Julian Roberto Marchesi, Mark Richard Nelson, Peter Kelleher et al. · 2019 · AIDS
  39. The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease
    Qingsong Zhang, Fengwei Tian, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen · 2019 · Trends in Food Science & Technology
  40. Bibliometric analysis of subject trends and knowledge structures of gut microbiota
    Yuanyi Yue, Xinyue Fan, Qiang Zhang, Yi-Ping Lu, Si Wu, Shuang Wang, Miao Yu, Changwan Cui, Zhengrong Sun · 2020 · World Journal of Clinical Cases
  41. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
    Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuanyong Guo · 2020 · Journal of Hepatocellular Carcinoma
  42. Effects of chitooligosaccharides on the rebalance of gut microorganisms and their metabolites in patients with nonalcoholic fatty liver disease
    Xiaoguo Ji, Mai Chen, Mengyao Zhao, Yudong Song, Yong Lin, Hao Yin, Liming Zhao · 2020 · Journal of Functional Foods
  43. Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients
    Doina Georgescu, Ioana Ioniță, Ana Lascu, Emil Florin Huţ, Simona Ruxanda Dragan, Oana Ancusa, Mihai Ionita, Despina Călămar-Popovici, Liviu-Andrei Georgescu, Daniel-Florin Lighezan · 2022 · International Journal of General Medicine
  44. Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients
    Lidan Yang, Yuzhao Dai, He He, Zhi Liu, Shenling Liao, Yu Zhang, Ga Liao, Zhenmei An · 2022 · Frontiers in Microbiology
  45. Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
    Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale · 2023 · Metabolites
  46. The role of the gut microbiome in the development of hepatobiliary cancers
    Neil Daniel, Flavia Genua, Mazda Jenab, Ana‐Lucia Mayén, Anastasia Chrysovalantou Chatziioannou, Pekka Keski‐Rahkonen, David J. Hughes · 2023 · Hepatology
  47. Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role?
    Elisa Pinto, Paola Meneghel, Fabio Farinati, Francesco Paolo Russo, Filippo Pelizzaro, Martina Gambato · 2023 · Digestive and Liver Disease
  48. Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
    Yi Wu, Wen Yin, Ping Hao, Yueru Chen, Lingyun Yu, Xingjian Yu, Yu Wu, Xiaocong Li, Wenjia Wang, Hui Zhou et al. · 2024 · International Journal of Biological Macromolecules
  49. Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review
    Yi‐Hsun Chen, Wei‐Kai Wu, Ming‐Shiang Wu · 2020 · International Journal of Molecular Sciences
  50. What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
    Natalia G. Vallianou, Junli Liu, Μaria Dalamaga · 2019 · Metabolism Open
  51. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience
    Yoga Fitriakusumah, Cosmas Rinaldi Adithya Lesmana, Winda Permata Bastian, Chyntia Olivia Maurine Jasirwan, Irsan Hasan, Marcellus Simadibrata K, Juferdy Kurniawan, Andri Sanityoso Sulaiman, Rino Alvani Gani · 2019 · BMC Gastroenterology
  52. Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
    Jihane N. Benhammou, Jonathan Lin, Shehnaz K. Hussain, Mohamed M. El-Kabany · 2020 · Hepatoma Research
  53. Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions
    Silvia C. Sookoian, Carlos Jose Pirola · 2021 · HepatoBiliary Surgery and Nutrition
  54. Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
    Sanjaya Kumar Satapathy, Pratik Banerjee, Joseph F. Pierre, Daleniece Higgins, Soma Dutta, Rajiv Prakash Heda, Sabrina D. Khan, Vamsee K. Mupparaju, Valeria R. Mas, Satheesh P. Nair et al. · 2020 · Transplantation Direct
  55. Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus
    Hamed Ebrahimzadeh Leylabadlo, Hossein Samadi Kafil, Safar Farajnia, Dariush Shanehbandi, Seyed Yaghoub Moaddab, Mohammad Mehdi Feizabadi, Reza Ghotaslou · 2021 · European Journal of Gastroenterology & Hepatology
  56. Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
    Masayoshi Ko, Kenya Kamimura, Takashi Owaki, Takuro Nagoya, Norihiro Sakai, Itsuo Nagayama, Yusuke Niwa, Osamu Shibata, Chiyumi Oda, Shinichi Morita et al. · 2021 · Disease Models & Mechanisms
  57. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
    Xinpei Gu, Qin Lu, Chengcheng Zhang, Zhewei Tang, Liuxi Chu · 2021 · Seminars in Liver Disease
  58. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
    Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim · 2021 · World Journal of Gastroenterology
  59. Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention
    Eftitan Y. Akam, Akua A. Nuako, Afkera Kesete Daniel, Fatima Cody Stanford · 2022 · Current Diabetes Reports
  60. Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance
    Jianjun Wu, Dingqi Zhang, Bo Zhu, Siqi Wang, Yongbin Xu, Congcong Zhang, Hailing Yang, Shunchun Wang, Ping Liu, Luping Qin et al. · 2022 · Chinese Medicine
  61. Effects of Cigarette Smoke Exposure on the Gut Microbiota and Liver Transcriptome in Mice Reveal Gut–Liver Interactions
    Lei Meng, Mengjun Xu, Youwen Xing, Chen Chen, Jian‐Dong Jiang, Xihui Xu · 2022 · International Journal of Molecular Sciences
  62. The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective
    Ilaria Demori, Elena Grasselli · 2023 · Nutrients
  63. Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
    Angela Horvath, Kristina Žukauskaitė, Olha Hazia, Irina Balázs, Vanessa Stadlbauer · 2023 · Endocrinology Diabetes & Metabolism
  64. Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non‐alcoholic fatty liver disease
    Minyu Zhang, Biyang Xiao, Xiaoqi Chen, Bingming Ou, Songtao Wang · 2023 · Acta Physiologica
  65. The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
    Jiali Yao, Beifang Ning, Jin Ding · 2025 · Gut Microbes
  66. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease
    Ashok S Raj, Erin Rose Shanahan, Cuong Duy Tran, Purnima Bhat, Linda Maria Fletcher, David Alan Vesey, Mark Morrison, Gerald Holtmann, Graeme A. Macdonald · 2019 · Clinical and Translational Gastroenterology
  67. Hepatic Inflammatory Response to Exogenous LPS Challenge is Exacerbated in Broilers with Fatty Liver Disease
    Wenqing Mei, Yarong Hao, Huilin Xie, Yingdong Ni, Ruqian Zhao · 2020 · Animals
  68. Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey
    Marta Moreno‐Torres, Guillem García-Llorens, Erika Moro, Rebeca Méndez, Alfonso Quintás‐Cardama, José Vicente Castell · 2021 · Scientific Reports
  69. Interplay between Intestinal Bacterial Communities and Unicellular Parasites in a Morbidly Obese Population: A Neglected Trinomial
    Jana Caudet-Esteban, María Trelis, Susana Cifre, José Miguel Soriano, Hortensia Rico, Juan Francisco Merino-Torres · 2022 · Nutrients
  70. Serum bile acid level and fatty acid composition in Chinese children with non‐alcoholic fatty liver disease
    Li Ping Lu, Yan Ping Wan, Pengcheng Xun, Ke Zhou, Cheng Chen, Si Cheng, Min Zhong Zhang, Chun Wu, Wei Wei Lin, Ying Jiang et al. · 2017 · Journal of Digestive Diseases
  71. Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice
    Xiaohan Yin, Weiyao Liao, Qingrong Li, Hongmin Zhang, Zihui Liu, Xinjie Zheng, Zheng Lin, Xiang Feng · 2020 · Journal of Functional Foods
  72. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study
    Jeung Hui Pyo, Tae Jun Kim, Hyuk Lee, Sung Chul Choi, Soo‐Jin Cho, Yoon‐Ho Choi, Yang Won Min, Byung‐Hoon Min, Jun Haeng Lee, Minwoong Kang et al. · 2020 · Journal of Gastroenterology and Hepatology
  73. Oral Pathogenic Bacteria and the Oral–Gut–Liver Axis: A New Understanding of Chronic Liver Diseases
    Yumeng Lei, Simin Li, Mingxin He, Zichun Ao, Jiadun Wang, Qingming Wu, Qiang Wang · 2023 · Diagnostics
  74. Tomato Pectin Ameliorated Hepatic Steatosis in High-Fat-Diet Mice by Modulating Gut Microbiota and Bile Acid Metabolism
    Pan Wang, Jing Sun, Wenting Zhao, Dan Wang, Yue Ma, Yuanyuan Zhao, Yubin Wang, Xiaoyan Zhao · 2024 · Journal of Agricultural and Food Chemistry
  75. Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention
    Giovanna Gallo, Gabriele Nalli, Francesco Baratta, Giovambattista Desideri, Carmine Savoia · 2025 · International Journal of Molecular Sciences
  76. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells
    Akira Kado, Takeya Tsutsumi, Kenichiro Enooku, Hidetaka Fujinaga, Kazuhiko Ikeuchi, Kazuya Okushin, Kyoji Moriya, Hiroshi Yotsuyanagi, Kazuhiko Koike · 2019 · Journal of Gastroenterology
  77. Malnutrition and liver disease in a developing country
    Asra Tus Saleha Siddiqui, Om Parkash, Syeda Amrah Hashmi · 2021 · World Journal of Gastroenterology
  78. Ligature induced periodontitis in rats causes gut dysbiosis leading to hepatic injury through SCD1/AMPK signalling pathway
    Xing Tian, Yajing Liu, Huixin Cheng, Miaomiao Bai, Jingning Chen, Huafeng Ji, Maozhang He, Keyang Chen · 2021 · Life Sciences
  79. Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids
    Biki Gupta, Ravi Prakash Rai, Michael Oertel, Reben Raeman · 2022 · Seminars in Liver Disease
  80. Insufficient or excessive dietary carbohydrates affect gut health through change in gut microbiota and regulation of gene expression of gut epithelial cells in grass carp (Ctenopharyngodon idella)
    Yanpeng Zhang, Yucheng Liu, Huan Ma, Manjie Sun, Xin Wang, Shengzhen Jin, Xiao‐Chen Yuan · 2022 · Fish & Shellfish Immunology
  81. Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis
    Li-ming Zhou, Jinhua Fan, Xu Minmin, Meng-yuan Xiong, Qiao-jiao Wang, Xue Chai, Xiao-duo Li, Xuegang Li, Xiao-li Ye · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  82. Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
    María Del Barrio, Lucía Lavín-Alconero, Álvaro Santos‐Laso, M. Arias, Aitor Odriozola, Juan Carlos Rodríguez-Duque, Coral Rivas, Paula Iruzubieta, Javier Crespo · 2023 · International Journal of Molecular Sciences
  83. Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
    Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Sergio Castorina, Stefano Puleo, Martina Barchitta, Antonella Agodi, Luisa Gallo, Gaetano La Greca, Saverio Latteri · 2023 · Biology
  84. Indole-3-carbinol and chlorogenic acid combination modulates gut microbiome and attenuates nonalcoholic steatohepatitis in a murine model
    Gabriel Prata Bacil, Guilherme Ribeiro Romualdo, Josias Rodrigues, Luı́s Fernando Barbisan · 2023 · Food Research International
  85. Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
    Xiaoxia Qiu, Sheng‐Li Cheng, Yan‐Hui Liu, Yu Lin Li, Rui Zhang, Nannan Li, Zheng Li · 2024 · World Journal of Gastroenterology
  86. PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells
    Wenfeng Zhang, Yan Liu, Mingbing Wu, Xiwen Zhu, Tao Wang, Kunlun He, Peizhi Li, Xiaoling Wu · 2017 · Journal of Physiology and Biochemistry
  87. Oral supplementation ofBifidobacterium longumstrain BR-108 alters cecal microbiota by stimulating gut immune system in mice irrespectively of viability
    Yuko Makioka‐Itaya, Takamitsu Tsukahara, 伊地知哲生, Ryo Inoüe · 2018 · Bioscience Biotechnology and Biochemistry
  88. Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers
    Antonio Gil‐Gómez, Paola Brescia, María Rescigno, Manuel Romero‐Gómez · 2021 · Seminars in Liver Disease
  89. Processes exacerbating apoptosis in non-alcoholic steatohepatitis
    Marta B. Afonso, Rui Eduardo Castro, Cecília M. P. Rodrigues · 2019 · Clinical Science
  90. Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    S. Jarmakiewicz-Czaja, A. Sokal-Dembowska, R. Filip · 2025 · Medicina
  91. The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease
    Wenjing Liu, Xian Zhou, Liyu Xiao, Xiaolan Huang, Dennis Chang, Xiaomei Zhong, Minjie Zeng, Yan‐Fang Xian, Yanfang Zheng, Wei Chieh Huang et al. · 2025 · Chinese Medicine
  92. Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
    Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner · 2025 · Hepatology
  93. Guanine Nucleotide‐Binding Protein G(i) Subunit Alpha 2 Exacerbates NASH Progression by Regulating Peroxiredoxin 1–Related Inflammation and Lipophagy
    Zechuan Zhang, Zetao Ji, Jianbo He, Yijun Lu, Wenfang Tian, Chang Zheng, Huihui Chen, Quan Zhang, Fei Yang, Minglu Zhang et al. · 2021 · Hepatology
  94. Gut Microbiome Diversity and Composition Are Associated with Habitual Dairy Intakes: A Cross-Sectional Study in Men
    Hajara Aslam, Fiona Collier, Jessica A. Davis, Thomas P. Quinn, Martin O’Hely, Julie Anne Pasco, Felice N. Jacka, Amy Loughman · 2021 · Journal of Nutrition
  95. Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition
    Junichi Iwamoto, Akira Honda, Teruo Miyazaki, Tadakuni Monma, Hajime Ueda, Yukio Morishita, Shoichiro Yara, Takeshi Thomas Hirayama, Tadashi Ikegami · 2021 · Hepatology Communications
  96. Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
    Eunju Park, Jin‐Ju Jeong, Sung‐Min Won, Satya Priya Sharma, Yoseph Asmelash Gebru, Raja Ganesan, Haripriya Gupta, Ki Tae Suk, Dong Joon Kim · 2021 · Cells
  97. Shrimp AHPND Causing Vibrio anguillarum Infection: Quantitative Diagnosis and Identifying Antagonistic Bacteria
    Huiyu Shen, Ting-Ting Song, Jiaqi Lü, Qiongfen Qiu, Jiong Chen, Jinbo Xiong · 2021 · Marine Biotechnology
  98. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
    Chenchen Bi, Geqiong Xiao, Chunyan Liu, Junwei Yan, Jiaqi Chen, Wenzhang Si, Jian Zhang, Zheng Liu · 2021 · Frontiers in Cell and Developmental Biology
  99. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
    Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli · 2022 · Critical Reviews in Microbiology
  100. Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
    Shuangjie Yang, Deshuai Yu, Junjie Liu, Yanfang Qiao, Shuxiao Gu, Ran Yang, Xinlou Chai, Wei Wang · 2023 · Frontiers in Endocrinology